Why the study?
The study was conducted to compare clinical outcomes of TAVI versus AVR for aortic stenosis in dialysis-dependent patients.
Does TAVI reduce mortality and complications compared to surgical AVR in dialysis-dependent patients with aortic stenosis?
Does TAVI reduce mortality and complications compared to surgical AVR in dialysis-dependent patients with aortic stenosis?
Answers are grounded in this paper and cite their sources.
In dialysis-dependent patients with aortic stenosis, TAVI is associated with lower early and 1-year mortality, fewer strokes, and shorter hospital stays compared to surgical AVR, though with a higher risk of new pacemaker implantation.
OBJECTIVES: This meta-analysis aims to compare the clinical outcomes of transcatheter aortic valve implantation (TAVI) versus aortic valve replacement (AVR) for aortic stenosis in dialysis-dependent patients. METHODS: Literature searches employed PubMed, Web of Science, Google Scholar and Embase to identify relevant studies. Bias-treated data were prioritized, isolated and pooled for analysis; raw data were utilized where bias-treated data were unavailable. Outcomes were analysed to assess for study data crossover. RESULTS: Literature search identified 10 retrospective studies; following data source analysis, five studies were included. Upon pooling of bias-treated data, TAVI was significantly favoured in early mortality [odds ratio (OR), 0.42; 95% confidence interval (95% CI), 0.19-0.92; I2 = 92%; P = 0.03], 1-year mortality (OR, 0.88; 95% CI 0.80-0.97; I2 = 0%; P = 0.01), rates of stroke/cerebrovascular events (OR, 0.71; 95% CI 0.55-0.93; I2 = 0%; P = 0.01) and blood transfusions (OR, 0.36; 95% CI 0.21-0.62; I2 = 86%; P = 0.0002). Pooling demonstrated fewer new pacemaker implantations in the AVR group (OR, 3.33; 95% CI 1.94-5.73; I2 = 74%; P ≤ 0.0001) and no difference in the rate of vascular complications (OR, 2.27; 95% CI 0.60-8.59; I2 = 83%; P = 0.23). Analysis including raw data revealed the length of hospital stay to favour TAVI with a mean difference of -9.20 days (95% CI -15.58 to -2.82; I2 = 97%; P = 0.005). CONCLUSION: Bias-treated meta-analysis comparing surgical AVR and TAVI favoured TAVI in early mortality, 1-year mortality, rates of stroke/cerebrovascular events and blood transfusions. There was no difference in the rates of vascular complications; however, TAVI required more pacemaker implantations. Data pooling including raw data revealed that the length of hospital admission favours TAVI.
No takes yet. Share an insight, caveat, or question.
Burton et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: